Medicine Compliance Aid Stability
ExforgeNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Tablets 5mg/80mg, 5mg/160mg, 10mg/160mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
7 January 2022